Tower Research Capital LLC (Trc) Cardiol Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.48 - $1.0 $9,084 - $18,926	18,926 Added 536.15%	22,456 $11,000
Q3 2022 Nov 10, 2022	SELL	$1.02 - $1.41 $1,002 - $1,386	-983 Reduced 21.78%	3,530 $4,000
Q2 2022 Aug 15, 2022	BUY	$1.03 - $2.05 $3,422 - $6,812	3,323 Added 279.24%	4,513 $6,000
Q1 2022 May 12, 2022	BUY	$1.25 - $2.31 $1,161 - $2,145	929 Added 355.94%	1,190 $2,000
Q4 2021 Feb 14, 2022	SELL	$1.83 - $4.86 $3,477 - $9,234	-1,900 Reduced 87.92%	261 $0
Q3 2021 Nov 15, 2021	BUY	$2.03 - $4.8 $4,386 - $10,372	2,161 New	2,161 $9,000

5.07M

5.2K

9.5K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $79.9M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.